Systole Health is sharpening its focus on cardio-kidney-metabolic, or CKM, care redesign with an upcoming expert-led virtual event aimed at cardiology and health system leaders. The April 8, 2026 discussion will feature CEO Dr. Simin Gharib Lee and Intermountain Health preventive cardiology leader Viet Le.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The session will explore why traditional cardiology clinic structures may be poorly aligned with complex CKM populations and what updated clinical models could look like inside health systems. Key themes include defining appropriate CKM care pathways, addressing capacity constraints, and understanding how physician and advanced practice provider teams can expand access without increasing burnout.
Systole Health is also expected to examine where technology can and cannot support this shift, emphasizing that care-model innovation, workflow optimization, and workforce leverage are central to its strategy. This suggests potential applications for analytics or operational efficiency tools targeting cardiology service lines facing rising demand and reimbursement pressure.
By positioning the event as an educational offering for cardiology service line and heart and vascular institute leaders, the company is leaning into a thought-leadership driven business development approach. Featuring a prominent Intermountain Health clinician and the editor of CardioSmart may help Systole Health build credibility, deepen relationships with large provider organizations, and shape emerging standards in CKM care.
If the webinar catalyzes pilot programs or broader collaborations, it could enhance Systole Health’s visibility and strengthen its value proposition in managing high-cost cardiometabolic populations. Overall, the week underscored Systole Health’s intent to influence cardiology care redesign and align its solutions with the operational and clinical needs of U.S. health systems.

